Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 212-343-5 | CAS number: 793-19-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2003-12-22 (date the test subtance was receveid) to 2004-09-29
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 004
- Report date:
- 2004
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Deviations:
- yes
- Remarks:
- 1) No data on mitogenic stimulation or the metaphase-arresting substance, 2) Only 100 metaphas e spreads scored per concentration.
- GLP compliance:
- no
- Type of assay:
- in vitro mammalian chromosome aberration test
Test material
- Reference substance name:
- Methyl N-benzyl-N-(3-methoxy-3-oxopropyl)-β-alaninate
- EC Number:
- 212-343-5
- EC Name:
- Methyl N-benzyl-N-(3-methoxy-3-oxopropyl)-β-alaninate
- Cas Number:
- 793-19-1
- Molecular formula:
- C15H21NO4
- IUPAC Name:
- methyl 3-[benzyl(3-methoxy-3-oxopropyl)amino]propanoate
- Details on test material:
- - Name of test material (as cited in study report): T 723
- Substance type: no data
- Physical state: pale yellow liquid
- Analytical purity: 100%
- Impurities (identity and concentrations): no data
- Composition of test material, percentage of components: no data
- Isomers composition: no data
- Purity test date: no data
- Lot/batch No.: no data
- Expiration date of the lot/batch: no data
- Stability under test conditions: no data
- Storage condition of test material: no data
- Other: no data
Constituent 1
- Specific details on test material used for the study:
- Description: Pale yellow liquid
Purity: 100 %
Date received: 2003-12-22
Storage conditions: Room temperature in the dark
Method
Species / strain
- Species / strain / cell type:
- other: human lymphocytes
- Details on mammalian cell type (if applicable):
- not applicable
- Additional strain / cell type characteristics:
- not applicable
- Metabolic activation:
- with and without
- Metabolic activation system:
- induced rat liver homogenate metabolising system (2%)
- Test concentrations with justification for top dose:
- - Preliminary toxicity test: 0, 12.9, 25.8, 51.6, 103.19, 206.38, 412.75, 825.5, 1651 and 3302 μg/mL, based on a 10mM maximum dose level.
- Group 1 (4-hour without S9): 0, 87.29, 174.59, 349.18, 523.77, 698.35 and 1047.53 µg/mL (0, 174.59, 349.18 and 698.35 μg/mL were selected for metaphase analysis.)
- Group 2 (4-hour with S9): 0, 87.29, 174.59, 349.18, 523.77, 698.35 and 1047.53 µg/mL (0, 174.59, 349.18 and 698.35 μg/mL were selected for metaphase analysis.)
- Group 3 (24-hour without S9): 0, 21.82, 43.65, 87.29, 174.59, 261.89 and 349.18 µg/mL (0, 43.65, 87.29 and 261.89 μg/mL were selected for metaphase analysis.) - Vehicle / solvent:
- - Vehicle used: no data
- Justification for choice of solvent/vehicle: no data
Controlsopen allclose all
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- mitomycin C
- Remarks:
- without metabolic activation; at 0.4 μg/ml for the 4(20) hour exposure and 0.2 μg/mL for the 24 hour continuous exposure (Groups 1 and 3 respectively)
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- Remarks:
- with metabolic activation; at 10 μg/ml for the 4(20) hour exposure (Group 2)
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: no data
DURATION
- Exposure duration: 4 hours (Groups 1 and 2); 24 hours (Group 3)
- Expression time (cells in growth medium): 20 hours (Groups 1 and 2) was provided in the study report as the expression period. However, no information was given on the time of addition of a spindle inhibitor; 0 hours (Group 3)
- Fixation time (start of exposure up to fixation or harvest of cells): 24 hours (all groups)
SPINDLE INHIBITOR (cytogenetic assays): no data
STAIN (for cytogenetic assays): no data
NUMBER OF REPLICATIONS:
Duplicate cultures were tested. Except where there was the need to clarify an equivocal response, only one of the duplicate cultures was assessed for the incidence of cells with chromosome aberrations.
NUMBER OF CELLS EVALUATED: 100 cells per evaluated culture.
DETERMINATION OF CYTOTOXICITY:
- Method: mitotic index (MI)
OTHER EXAMINATIONS:
- Determination of polyploidy: yes
- Determination of endoreplication: investigated - Evaluation criteria:
- A positive response was recorded for a particular treatment if the % cells with aberrations, excluding gaps, markedly exceeded that seen in the concurrent control, either with or without a clear dose-relationship. For modest increases in aberration frequency a dose response relationship is generally required and appropriate statistical tests may be applied in order to record a positive response.
- Statistics:
- no data
Results and discussion
Test resultsopen allclose all
- Species / strain:
- other: human lymphocytes
- Metabolic activation:
- without
- Genotoxicity:
- positive
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- other: human lymphocytes
- Metabolic activation:
- with
- Genotoxicity:
- other: dose related increases in gap-type aberrations only
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH: no data
- Effects of osmolality: no data
- Evaporation from medium: no data
- Water solubility: no data
- Precipitation: There was a cloudy precipitate of test substance observed at and above 1396.7 µg/ml in all exposure groups.
RANGE-FINDING/SCREENING STUDIES:
- Microscopic assessment of the slides prepared from the treatment cultures showed that metaphase cells were present at up to 698.35 µg/mL in the 4 hour pulse exposure groups and at up to 349.18 µg/mL in the 24 hour continuous exposure group.
- A dose-related increase in toxicity in all of the exposure groups was observed. Furthermore, in both 4(20)-hour pulse exposure groups there was approximately 50% mitotic inhibition at 698.35 µg/mL. Therefore, the selection of the dose range for the main test was based on toxicity.
COMPARISON WITH HISTORICAL CONTROL DATA:
All of the vehicle control cultures had frequencies of cells with chromosome aberrations within the expected range. The positive control materials induced statistically significant increases in the frequency of cells with aberrations. It was therefore considered that the metabolic activation system was shown to be functional and the test method itself was operating as expected.
ADDITIONAL INFORMATION ON CYTOTOXICITY:
A microscopic assessment of the slides showed that metaphase cells were present at up to 698.35 μg/ml in both the 4(20)-hour exposure groups and at up to 261.89 μg/ml in the 24-hour continuous exposure group. The test material induced mitotic inhibition in all exposure groups. In the 4 hour pulse exposures the ideal of 50% mitotic inhibition was achieved at 698.35 and 523.77 μg/ml, with and without S9 respectively. In the 24-hour exposure group there was approximately 60% mitotic inhibition at 261.89 μg/ml. Dose selection for metaphase analysis was limited by toxicity in all exposure groups. - Remarks on result:
- other: Groups 1 and 3: 4 and 24-hour exposure period without S9-mix
Any other information on results incl. tables
The test substance induced statistically significant increases in the frequency of cells with aberrations at the maximum dose levels selected for scoring, in both exposure groups without S9. In the 4 -hour exposure with metabolic activation (Group 2) there were dose related increases in gap-type aberrations only. These were considered to be unusual but of less clastogenic importance than the aberration types observed in Groups 1 and 3.
The test substance did not induce a statistically significant increase in the numbers of polyploid cells in any of the exposure groups.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results:
positive without metabolic activation
The test substance induced statistically significant increases in the frequency of cells with chromosome aberrations (without gaps) in the absence of a liver enzyme metabolizing system after a 4-hour exposure with a 20-hour recovery and a 24-hour continuous exposure. The test substance was therefore considered to be clastogenic to human lymphocytes in vitro.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.